|
Michael E. Mendelsohn, MD, FACC, is the Executive Director of the Molecular Cardiology Research Institute at New England Medical Center and the first recipient of the Elisa Kent Mendelsohn Professorship of Molecular Cardiology and Medicine at Tufts University School of Medicine. Dr. Mendelsohn is also the Vice-Chairman for Scientific Affairs of the Department of Medicine and Chairman of the Research Executive Committee for Tufts-New England Medical Center. Dr. Mendelsohn is an international leader in the study of molecular vascular biology. As a physician-scientist, Dr. Mendelsohn has focused on signal transduction pathways regulating vascular tone and function. His laboratory has contributed importantly to deciphering the mechanisms of action of endogenous vascular protective molecules, including estrogen/estrogen receptors and nitric oxide/cyclic GMP signaling pathways in cardiovascular physiology and disease. Dr. Mendelsohn joined the Cardiology Division at Tufts-New England Medical Center in 1993 as the Director of the Molecular Cardiology Research Center and an Associate Professor of Medicine, Tufts University School of Medicine. Dr. Mendelsohn received his B.A. magna cum laude from Amherst College in 1978 and his M.D. from Harvard Medical School in 1982, followed by residency in Internal Medicine and fellowship in Cardiovascular Medicine at Brigham and Women's Hospital. He was a member of the staff of the BWH Cardiology Division from 1988-1993 and an Assistant Professor of Medicine at Harvard Medical School. Dr. Mendelsohn's laboratory is funded principally by the National Institutes of Health. He has been the Principal Investigator on numerous NIH awards, including a Specialized Center of Research in Ischemic Heart Disease and a Program Project Grant studying molecular mechanisms of vascular relaxation. He is the recipient of an Established Investigatorship from the American Heart Association, the Sir William Osler Young Investigator Award of the Interurban Clinical Club, and both the Distinguished Faculty Award and the Milton O. and Natalie V. Zucker Faculty Award for Outstanding Research from Tufts University School of Medicine. Dr. Mendelsohn was an Invited Speaker at the Nobel Symposium, "Estrogen and Women's Health" in Karlskoga, Sweden in 1999 and the Chairman of the Experimental Cardiovascular Sciences Study Section of the NIH from 2000-2002, and is an Invited Speaker to the 2008 Nobel Conference, "Recent Advances in Understanding Estrogen Signaling" in Stockholm, Sweden. Dr. Mendelsohn's awards also include election to the American Society of Clinical Investigation (ASCI), the Association of University Cardiologists (AUC) and the Association of American Physicians (AAP). | 